Jon Dale

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

Pharmacology and Management of the Vitamin K Antagonists

Prosthetic Heart Valves

A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis

Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety

Thrombotic and Bleeding Complications of Prosthetic Heart Valves

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Antithrombotic Therapy in Valvular Heart Disease

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy

Oral Anticoagulant Therapy

New Antithrombotic Drugs

Percutaneous Repair or Surgery for Mitral Regurgitation

Platelet-Active Drugs

Emergency Hospitalizations for Adverse Drug Events in Older Americans

Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin

Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis

A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Platelet Activation and Atherothrombosis

Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation

Antiplatelet Drugs

Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention

Antiplatelet Drugs

Stroke

Fish Intake, Contaminants, and Human Health

Oral Anticoagulants

Burden of valvular heart diseases: a population-based study

Management of acute myocardial infarction in patients presenting with ST-segment elevation

Role of transesophageal echocardiography in the diagnosis and management of prosthetic valve thrombosis

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Antithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic

Trial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart Valves

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes

The Pharmacology and Management of the Vitamin K Antagonists

Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment

Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin

Hemorrhagic Complications of Anticoagulant Treatment

Antithrombotic and Thrombolytic Therapy for Valvular Disease

Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Hemorrhagic Complications of Anticoagulant Treatment

Treatment of Infections Associated with Surgical Implants

Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: A randomized trial in patients with mechanical prosthetic heart valves

External validity of randomised controlled trials: “To whom do the results of this trial apply?”

Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the st. jude medical prosthesis

Hemorrhagic Complications of Anticoagulant Treatment

Low-dose warfarin and low-dose aspirin in the primary prevention of ischemic heart disease

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

Platelet-Active Drugs

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects

Antithrombotic Therapy in Valvular Heart Disease

Antiplatelet and anticoagulation for patients with prosthetic heart valves

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Long-term follow-up after isolated aortic valve replacement

Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk.

Infections in bionic man: The pathobiology of infections in prosthetic devices—Part II

Hypercoagulopathy in Stroke Patients with Nonvalvular Atrial Fibrillation: Hematologic and Cardiologic Investigations

Comparison of two levels of anticoagulant therapy in patients with substitute heart valves

Antithrombotic Therapy in Valvular Heart Disease

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

Antiplatelet and anticoagulation for patients with prosthetic heart valves

Comparison of High-Dose With Low-Dose Aspirin in Patients With Mechanical Heart Valve Replacement Treated With Oral Anticoagulant

Anticoagulation for Noncardiac Procedures in Patients With Prosthetic Heart Valves

Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

Aspirin and Other Platelet-Active Drugs

Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.

Hemorrhagic Complications of Long-term Anticoagulant Therapy

Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: A metaanalysis

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.

Avoiding Central Nervous System Bleeding During Antithrombotic Therapy

Biomaterial-Centered Infection: Microbial Adhesion Versus Tissue Integration

Hemorrhagic Complications of Anticoagulant Treatment

Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation

Role of Prostacyclin in the Cardiovascular Response to Thromboxane A ₂

Replacement of aortic valve combined with myocardial revascularization: determinants of early and late risk for 500 patients, 1967-1981.

Low-Intensity Oral Anticoagulant Plus Low-Dose Aspirin During the First Six Months Versus Standard-Intensity Oral Anticoagulant Therapy After Mechanical Heart Valve Replacement: A Pilot Study of Low-Intensity Warfarin and Aspirin in Cardiac Prostheses (LIWACAP)

Hemorrhagic Complications of Long-term Anticoagulant Therapy

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

Aspirin and Other Platelet-Active Drugs

Platelets, endothelium, and vasospasm.

Management of Deep Vein Thrombosis and Pulmonary Embolism

Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamole

Hemorrhagic Complications of Anticoagulant Treatment

Interactions of Warfarin with Drugs and Food

Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary Arteries

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack

High-Dose Atorvastatin after Stroke or Transient Ischemic Attack

Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.

The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation

Platelet Activation in Unstable Coronary Disease

Lipoprotein(a), Other Lipoproteins and Hemostatic Profiles in Patients with Ischemic Stroke: The Relation to Cardiogenic Embolism

Randomized Trial of Low Molecular Weight Heparin (Dalteparin) in Prevention of Left Ventricular Thrombus Formation and Arterial Embolism After Acute Anterior Myocardial Infarction: The Fragmin in Acute Myocardial Infarction (FRAMI) Study 11This study was supported by grants from the Norwegian Council on Cardiovascular Diseases, Oslo, Norway and Pharmacia AB, Stockholm, Sweden.

Platelet functions in patients with aortic ball valves

Effects of dipyridamole and acetylsalicylic acid on platelet functions in patients with aortic ball-valve prostheses

Reduced platelet adhesiveness in patients with prosthetic ball valves: Relation to adenosine diphosphate and mechanical trauma

Effects of a selective thromboxane synthetase inhibitor, dazoxiben, and of acetylsalicylic acid on myocardial ischemia in patients with coronary artery disease

Prevention of arterial thromboembolism with acetylsalicylic acid

Long-term results after aortic valve replacement with four different prostheses

Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement

CAN ACETYLSALICYLIC ACID ALONE PREVENT ARTERIAL THROMBOEMBOLISM? A PILOT STUDY IN PATIENTS wITH AORTIC BALL VALVE PROSTHESES

Arterial thromboembolic complications in patients with Björk-Shiley and Lillehei-Kaster aortic disc valve prostheses

Arterial thromboembolic complications in patients with Starr-Edwards aortic ball valve prostheses